Fibrodysplasia ossificans progressiva in China

descriptionPublicationkeyboard_double_arrow_right Article 01 Apr 2018 English Publisher:Elsevier BVJournal:Bone, volume 109, pages 101-103 (issn: 8756-3282,

Copyright policy )

Authors: Dunmin, She; Keqin, Zhang;

doi: 10.1016/j.bone.2017.11.016

pmid: 29175272

Fibrodysplasia ossificans progressiva in China

- Summary
- Subjects
- Metrics

Abstract

Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare and devastating disorder characterized by cumulative episodes of progressive heterotopic ossification. It is estimated that there exist 600-700 patients in Mainland China. Nevertheless, due to the rarity, many FOP patients were initially misdiagnosed. Until now fewer than 150 patients have been identified in Mainland China. This review summarizes the epidemiology and clinical features of FOP patients, the progress of clinical and basic research in China, and the future of FOP care in China.

Related Organizations

Tongji University
China (People's Republic of)
Tongji Hospital
China (People's Republic of)

Keywords

China, Myositis Ossificans, Disease Progression, Animals, Humans

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	9
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%